Selected article for: "low level and Supplementary table"
Author: Nikas, Jason B.
Title: Inflammation and Immune System Activation in Aging: A Mathematical Approach
  • Document date: 2013_11_19
    • ID: 2yvyiiuy_11
    Snippet: The results of my study, in addition to providing evidence for this dual process of chronic, low-level neuroinflammation/immune-system-activation in connection with normal aging, suggest a means of a potential treatment. Regardless of the exact causal sequence of the events, administration of anti-inflammatory drugs/chemicals that can normalize the expression of the aforementioned 27 genes of inflammation/immune-system-activation may decelerate t.....
    Document: The results of my study, in addition to providing evidence for this dual process of chronic, low-level neuroinflammation/immune-system-activation in connection with normal aging, suggest a means of a potential treatment. Regardless of the exact causal sequence of the events, administration of anti-inflammatory drugs/chemicals that can normalize the expression of the aforementioned 27 genes of inflammation/immune-system-activation may decelerate the onset of the aging process, as well as the aging process itself, and mitigate its symptoms by restoring synaptic plasticity throughout the hippocampus and possibly throughout the rest of the brain. Supplementary Table 6 lists all those 27 most significant genes as possible targets for the development of such an anti-inflammatory treatment, along with potential candidate drugs/chemicals that are known (via Ingenuity Pathway Analysis) to interact with those genes.

    Search related documents:
    Co phrase search for related documents
    • low level and possible target: 1, 2
    • low level and potential candidate: 1
    • low level and potential treatment: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11
    • low level and significant gene: 1, 2, 3
    • low level and study result: 1, 2, 3, 4
    • normal aging and potential treatment: 1
    • normal aging and supplementary table: 1, 2
    • normal aging and synaptic plasticity: 1, 2
    • possible target and potential candidate: 1, 2
    • possible target and potential treatment: 1, 2, 3, 4, 5, 6, 7
    • possible target and significant gene: 1, 2
    • possible target and supplementary table: 1, 2, 3, 4
    • potential candidate and study result: 1
    • potential candidate and supplementary table: 1
    • potential treatment and significant gene: 1
    • potential treatment and study result: 1, 2, 3, 4, 5, 6
    • significant gene and study result: 1, 2
    • significant gene and supplementary table: 1, 2, 3
    • supplementary table and synaptic plasticity: 1